Results 121 to 130 of about 4,909 (142)

A novel prognostic risk-scoring system based on m⁵C methylation regulator-mediated patterns for glioma patients. [PDF]

Mol Ther Oncol
Wen Y, Chen X, Li R, Xie H, Zhi S, Wang K, Yi S, Liang W, Hu H, Rao S, Gao X.   +10 more
europepmc   +1 more source

DNMT2 inhibits anaplastic thyroid cancer progression by downregulating 5'tiRNA^Gly-GCC production. [PDF]

Cell Death Dis
Zhou R, Li B, Cao M, Wu Z, Xia F, Li X.
europepmc   +1 more source

Enhancing plant antiviral responses and productivity through the elimination of m⁵C methyltransferase. [PDF]

Sci Adv
Jiang Y, Liu P, Zhang M, Yong B, Yin J, Chen L, Shi C, Li P, Guo Y, Hu H, Feng L, Chen L, Zhang T, Liu J, Zhong K, Zhou X, Chen F, Chen J, Yang J.   +18 more
europepmc   +1 more source

M⁵C-driven stabilization of SERPINB5 promotes cervical cancer progression and chemotherapy resistance. [PDF]

Cell Death Dis
Liu J, Zhou L, Yao P, Zhang N, Guo X, Chen F, Yang S, Du X, Wang H, Zhou Y, Chen Y, Zhou L.   +11 more
europepmc   +1 more source

Regulation of RNA methylation linked to drug resistance in gastric cancer. [PDF]

Front Cell Dev Biol
Yang Z, Ma Y, Xu Z, Liu H, Gu X, Sun J.
europepmc   +1 more source

NSUN5 and RNA m⁵C epitranscriptomic regulation in tumor progression. [PDF]

Front Cell Dev Biol
Zhou Q, Li C, Jiang X, Yuan Y, Zhou Q, Wang Q, Jiang L.   +6 more
europepmc   +1 more source

Deep learning model and omics screening highlight angiotensinogen as a 5-methylcytosine (m⁵C) regulated mediator of tumor-microenvironment communication in liver cancer. [PDF]

Front Immunol
Pang H, Wang L, Li Y, Zhou Y.
europepmc   +1 more source

Therapy-induced mRNA, rRNA and tRNA methylation alterations confer tolerance phenotype in tumor cells: mechanism and implications. [PDF]

Int J Biol Sci
Jiang A, Liu S, Li Z, Zhang X, Duan M, Li B.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

NOP2-mediated m5C methylation of XPD is associated with hepatocellular carcinoma progression

Neoplasma, 2023
Hepatocellular carcinoma (HCC) is a common malignant tumor with high mortality. Our previous study has confirmed that XPD acts as an anti-oncogene and is downregulated in HCC. The mechanism of XPD downregulation in HCC is unclear. In this work, we obtained the datasets related to HCC patients from GSE76427, LIRI-JP, and TCGA-LIHC cohorts.
Guo-Fang, Sun, Hao, Ding
openaire   +2 more sources